News

Keep up to date with the location and times of the Public Security Police (PSP) speed radars in July - from North to South of ...
MAIA Biotechnology Announces New Updates from Phase 2 Trial of Novel Cancer Treatment AgentTHIO followed by cemiplimab shown to be well tolerated throughout trial, with far lower toxicity compared ...
"Breakfast is eggs on toasted McCambridges brown bread, and sometimes half an avocado, because I’m financially reckless." Maia Dunphy: "My weekends are not for formal exercise. Although now that ...
Microsoft’s ambitious push into custom AI chip development has reportedly hit a major roadblock. According to a report from The Information, the tech giant’s next-generation Maia AI chip, code ...
Maia Biotechnology, Inc. (NYSE American:MAIA), a biotechnology company with a market capitalization of $52.7 million, announced it has entered into a stock purchase agreement with Prevail Partners, ...
Maia Biotechnology, Inc. (NYSE American:MAIA), a biotechnology company with a market capitalization of $52.7 million, announced it has entered into a stock purchase agreement with Prevail Partners ...
Frankfurt: Unseeded Brazilian Beatriz Haddad Maia edged out seventh seed Elina Svitolina of Ukraine 3-6, 6-4, 7-6 (9-7) in an enthralling last 16 clash on the Bad Homburg grass on Wednesday. Haddad ...
MAIA Biotechnology Inc., a clinical-stage biopharmaceutical company focused on developing targeted immunotherapies for cancer, has entered into a clinical master supply agreement with Roche.
CHICAGO - MAIA Biotechnology, Inc. (NYSE American:MAIA), a $52.43 million market cap biotechnology company currently trading at $1.73 per share, has appointed two oncologists specializing in ...